drugset / Trial / NCT04730609
Dexmedetomidine for Intraoperative Shivering in Scheduled Elective Cesarean Delivery
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the optimum dose of Dexmedetomidine to stop shivering in 90% of patients who experience shivering during scheduled elective cesarean deliveries.
Timeline
- Start
- 2021-09-21
- Primary completion
- 2026-08
- Completion
- 2026-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexmedetomidine | Other / unclassified | 10 ug | Intravenous |